3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Burkitt Lymphoma
3
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
2
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Leukemia, Biphenotypic, Acute
2
Hematologic Neoplasms
1
Blastic Plasmacytoid Dendritic Cell Neoplasm
1
Interventions
Dexamethasone
124
Lenalidomide
72
daratumumab
71
Bortezomib
58
pomalidomide
47
carfilzomib
42
Cyclophosphamide
39
Calcium Dobesilate
36
Specimen Handling
31
Biopsy
29
Magnetic Resonance Spectroscopy
26
belantamab mafodotin
22
isatuximab
21
fludarabine
20
iberdomide
18
talquetamab
17
Melphalan
15
dexamethasone acetate
14
dexamethasone 21-phosphate
14
auricularum
14
fludarabine phosphate
13
elotuzumab
12
selinexor
10
tocilizumab
9
X-Rays
8
Nivolumab
8
trametinib
7
Whole-Body Irradiation
7
Sirolimus
7
Mycophenolic Acid
6
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Multiple Myeloma
×
Medrol Veriderm
×
90 days
×
Clear all
No trials found.